Problem

Ember addresses the growing difficulty of managing healthcare revenue cycle work manually. Payers are using increasingly sophisticated rules and automation to deny claims, while revenue-cycle teams still rely on labor-intensive audits and reactive cleanup. Denials that could be recovered often become permanent write-offs as claims sit in accounts receivable and appeal windows close, directly reducing provider margins and diverting staff time from higher-value work.

The central use case is revenue integrity: catching coding, documentation, and payer-policy problems before a claim is submitted, then recovering revenue when denials occur. For surgery centers, physician groups, and health systems, this means reducing preventable denials while ensuring that providers are properly paid for the care they deliver.

Product / Service

Ember is an AI-native healthcare revenue-integrity and revenue-cycle platform. Its workflows audit encounters before billing and manage denials afterward. The system reviews clinical records, payer policies, claim details, and contract terms; identifies the likely root cause of a denial; retrieves supporting evidence; drafts a cited appeal; and tracks the claim through adjudication. Its earlier product positioning also included medical scribing and autonomous coding, including real-time checks for ICD-10, CPT, DRG, bundling, modifiers, and payer documentation requirements.

The platform sits on top of existing EHR and practice-management systems rather than requiring a wholesale replacement. Customers can submit an initial batch of cases and receive analysis within days, with full integration typically taking weeks. Ember reports that live deployments have reduced denials, saved administrative labor, improved clean-claim rates, and produced positive return on investment by recovering revenue that providers had previously written off.

Market

Ember competes in healthcare revenue-cycle management, revenue integrity, denial prevention, medical coding, and adjacent clinical-documentation software. Its positioning is differentiated toward proactive, AI-driven prevention and recovery rather than only downstream billing operations. Possible competitors and substitutes named in company-directory research include Waystar, Charta Health, and Suki; Waystar is a large revenue-cycle platform, Charta is focused on AI-assisted chart review and denial prevention, and Suki is more adjacent in ambient clinical documentation.

The company appears to be commercial and post-revenue rather than pre-revenue. Ember's site reports more than 200 providers live and measured deployment outcomes including 57% fewer denials, 3.3x first-month ROI, more than 100 hours of monthly staff time saved, and a 9.3% increase in net revenue per appointment. It announced a $4.3 million seed round led by Nexus Venture Partners with Y Combinator participating in November 2025, while PitchBook lists the company as generating revenue; no specific revenue figure is disclosed in the available evidence.